STARTING AND STAYING ON WEGOVY®
If you‘re an adult with obesity, or with overweight and at least one weight-related medical problem, it‘s important to have what you need when you start using Wegovy® pen or taking Wegovy® pill. Along with a reduced-calorie diet and increased physical activity, Wegovy® can help you lose weight and keep it off.
Wegovy® your way
Whether you use a once-weekly pen or take a once-daily pill,
select your product below to see details on how to take and store it, plus helpful tips.
Get to know the dosing of the once-daily Wegovy® pill
Get to know the dosing of the once-weekly Wegovy® pen
FAQs about Wegovy®
Semaglutide is the active ingredient in Wegovy® and is what helps you lose weight, along with diet and exercise. Novo Nordisk® is the only company in the United States with FDA-approved medicines containing semaglutide.
Compounded or knockoff semaglutide has not been approved by the FDA and has not been proven to be safe or effective.
If it's not made by Novo Nordisk®, it’s not FDA-approved semaglutide.
FDA=Food and Drug Administration.
Your brain gets signals from different places in your body. Some of these signals are called appetite hormones, like GLP-1 (glucagon-like peptide-1), which help regulate how much food you eat. Wegovy® works like GLP-1 to regulate appetite and calorie intake by helping to reducing appetite, so you eat less and lose weight.
Semaglutide is the active ingredient in Wegovy®, which is part of a class of medications called GLP-1 (glucagon-like peptide-1) receptor agonists, often referred to as GLP-1's. Wegovy® pen was the first once-weekly GLP-1 approved by the FDA for weight loss. Wegovy® is also the first GLP-1 daily oral medication for weight loss.
FDA=Food and Drug Administration
People respond to medication, including Wegovy®, differently, so there is no set time when you can expect to see results with Wegovy®. Ask your healthcare professional about what might be realistic for you.
For adults with obesity, along with diet and exercise, Wegovy® is available in 2 forms-a pen and pill. The Wegovy® pen allows you to self-inject the medicine once a week and the Wegovy® pill is taken once daily to help you lose weight and keep it off.
Become a WEGOVY® INSIDER
Stay in the know with the latest Wegovy® news, including safety information and what you might expect from treatment.
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® may cause serious side effects, including:
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.